CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 8-K Event Executive or director change
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award CFO and CBO acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale 10% owner sold 18 shares at $19.00 ($342)
- 8-K Event Other events
- 4/A Insider Changes in Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 9,798 shares at $19.00 ($186,162)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
Page 16 of 25 · 496 filings